CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Calcitonin gene-related peptide (CGRP) is a neuropeptide with diverse physiological
functions. Its two isoforms (α and β) are widely expressed throughout the body in sensory …
functions. Its two isoforms (α and β) are widely expressed throughout the body in sensory …
Migraine and the trigeminovascular system—40 years and counting
The underlying causes of migraine headache remained enigmatic for most of the 20th
century. In 1979, The Lancet published a novel hypothesis proposing an integral role for the …
century. In 1979, The Lancet published a novel hypothesis proposing an integral role for the …
[HTML][HTML] Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles
H Hautakangas, BS Winsvold, SE Ruotsalainen… - Nature …, 2022 - nature.com
Migraine affects over a billion individuals worldwide but its genetic underpinning remains
largely unknown. Here, we performed a genome-wide association study of 102,084 …
largely unknown. Here, we performed a genome-wide association study of 102,084 …
CGRP and the trigeminal system in migraine
S Iyengar, KW Johnson, MH Ossipov… - … : The Journal of Head …, 2019 - Wiley Online Library
Objective The goal of this narrative review is to provide an overview of migraine
pathophysiology, with an emphasis on the role of calcitonin gene‐related peptide (CGRP) …
pathophysiology, with an emphasis on the role of calcitonin gene‐related peptide (CGRP) …
Efficacy and safety of galcanezumab for the prevention of episodic migraine: results of the EVOLVE-2 phase 3 randomized controlled clinical trial
V Skljarevski, M Matharu, BA Millen… - …, 2018 - journals.sagepub.com
Introduction Galcanezumab is a humanized monoclonal antibody binding calcitonin gene-
related peptide, used for migraine prevention. Methods A global, double-blind, 6-month …
related peptide, used for migraine prevention. Methods A global, double-blind, 6-month …
Effect of fremanezumab compared with placebo for prevention of episodic migraine: a randomized clinical trial
DW Dodick, SD Silberstein, ME Bigal, PP Yeung… - Jama, 2018 - jamanetwork.com
Importance Fremanezumab, a fully humanized monoclonal antibody that targets calcitonin
gene-related peptide, may be effective for treating episodic migraine. Objective To assess …
gene-related peptide, may be effective for treating episodic migraine. Objective To assess …
Prosocial motives underlie scientific censorship by scientists: A perspective and research agenda
Science is among humanity's greatest achievements, yet scientific censorship is rarely
studied empirically. We explore the social, psychological, and institutional causes and …
studied empirically. We explore the social, psychological, and institutional causes and …
A phase‐by‐phase review of migraine pathophysiology
DW Dodick - Headache: the journal of head and face pain, 2018 - Wiley Online Library
Migraine is a common, disabling neurological disorder characterized by multiple phases:
premonitory, aura, headache, postdrome, and interictal. Our understanding of the …
premonitory, aura, headache, postdrome, and interictal. Our understanding of the …
[HTML][HTML] Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine
Migraine is a neurological ailment that is characterized by severe throbbing unilateral
headache and associated with nausea, photophobia, phonophobia and vomiting. A full and …
headache and associated with nausea, photophobia, phonophobia and vomiting. A full and …
The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine
S Iyengar, MH Ossipov, KW Johnson - Pain, 2017 - journals.lww.com
Calcitonin gene–related peptide (CGRP) is a 37-amino acid peptide found primarily in the C
and Aδ sensory fibers arising from the dorsal root and trigeminal ganglia, as well as the …
and Aδ sensory fibers arising from the dorsal root and trigeminal ganglia, as well as the …